At the same time, as tumor growth slowed, the percentage of CD8+ T cells with enhanced effector molecule expression significantly increased in pancreatic tumors because the depletion of CD8+ T cells eliminated the benefits of macrophage targeting. The gene discussed is CD8A; the disease is pancreatic neoplasm.